Impact of Nucleos(t)ide Reverse Transcriptase Inhibitors on Blood Telomere Length Changes in a Prospective Cohort of Aviremic HIV–Infected Adults

Rocio Montejano,Natalia Stella-Ascariz,Susana Monge,Jose I. Bernardino,Ignacio Pérez-Valero,María Luisa Montes,Eulalia Valencia,Luz Martín-Carbonero,Victoria Moreno,Juan González-García,Javier Rodriguez-Centeno,Berta Rodes,Andres Esteban Cantos,Belén Alejos,Rosa de Miguel,Arnalich F,Rosario Perona,José Ramón Arribas

Impact of Nucleos(t)ide Reverse Transcriptase Inhibitors on Blood Telomere Length Changes in a Prospective Cohort of Aviremic HIV–Infected Adults

2018

Rocio Montejano
Natalia Stella-Ascariz
Susana Monge
Jose I. Bernardino
Ignacio Pérez-Valero
María Luisa Montes
Eulalia Valencia
Luz Martín-Carbonero
Victoria Moreno
Juan González-García
Javier Rodriguez-Centeno
Berta Rodes
Andres Esteban Cantos
Belén Alejos
Rosa de Miguel
Arnalich F
Rosario Perona
José Ramón Arribas

This work was supported by the Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (grants PI13/01467 and PI14/01495 [supported by the European Regional Development Fund], Rio Hortega fellowship [to R. d. M.], and predoctoral fellowship [to N. S.-A.]).

Keywords:

Prospective cohort study
Tenofovir
Telomere
Virology
Abacavir
Telomerase
Medicine
Reverse transcriptase
Reverse-transcriptase inhibitor
Oncology
Internal medicine
Lamivudine
Regimen
Cohort

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations